Selected research
Industry Research
Metformin Drugs Industry Research Report 2026
Market perspective
The global Metformin Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metformin Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metformin Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metformin Drugs include Alkem, Apotex, Atlas Pharmaceuticals, Bristol-Myers Squibb, Dr. Reddy’s Laboratories, Mallinckrodt, Teva Pharmaceuticals, Torrent Pharmaceuticals and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metformin Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metformin Drugs Market by Company
Alkem
Apotex
Atlas Pharmaceuticals
Bristol-Myers Squibb
Dr. Reddy’s Laboratories
Mallinckrodt
Teva Pharmaceuticals
Torrent Pharmaceuticals
Viatris
Novartis
Sun Pharmaceutical Industries
Metformin Drugs Segment by Type
50 Tablets
100 Tablets
Other
Metformin Drugs Segment by Application
Hospital
Drugs Stores
Metformin Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metformin Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metformin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 Tablets
- 100 Tablets
- Other
Applications
- Hospital
- Drugs Stores
Companies covered
- Alkem
- Apotex
- Atlas Pharmaceuticals
- Bristol-Myers Squibb
- Dr. Reddy’s Laboratories
- Mallinckrodt
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
- Viatris
- Novartis
- Sun Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metformin Drugs Market Size (2021-2032)
- 2.2.2 Global Metformin Drugs Sales (2021-2032)
- 2.2.3 Global Metformin Drugs Market Average Price (2021-2032)
- 2.3 Metformin Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50 Tablets
- 2.3.3 100 Tablets
- 2.3.4 Other
- 2.4 Metformin Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drugs Stores
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metformin Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metformin Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Metformin Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Metformin Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Metformin Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metformin Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metformin Drugs, Product Type & Application
- 3.8 Global Manufacturers of Metformin Drugs, Established Date
- 3.9 Global Metformin Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Alkem
- 4.1.1 Alkem Company Information
- 4.1.2 Alkem Business Overview
- 4.1.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Alkem Metformin Drugs Product Portfolio
- 4.1.5 Alkem Recent Developments
- 4.2 Apotex
- 4.2.1 Apotex Company Information
- 4.2.2 Apotex Business Overview
- 4.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Apotex Metformin Drugs Product Portfolio
- 4.2.5 Apotex Recent Developments
- 4.3 Atlas Pharmaceuticals
- 4.3.1 Atlas Pharmaceuticals Company Information
- 4.3.2 Atlas Pharmaceuticals Business Overview
- 4.3.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Atlas Pharmaceuticals Metformin Drugs Product Portfolio
- 4.3.5 Atlas Pharmaceuticals Recent Developments
- 4.4 Bristol-Myers Squibb
- 4.4.1 Bristol-Myers Squibb Company Information
- 4.4.2 Bristol-Myers Squibb Business Overview
- 4.4.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bristol-Myers Squibb Metformin Drugs Product Portfolio
- 4.4.5 Bristol-Myers Squibb Recent Developments
- 4.5 Dr. Reddy’s Laboratories
- 4.5.1 Dr. Reddy’s Laboratories Company Information
- 4.5.2 Dr. Reddy’s Laboratories Business Overview
- 4.5.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio
- 4.5.5 Dr. Reddy’s Laboratories Recent Developments
- 4.6 Mallinckrodt
- 4.6.1 Mallinckrodt Company Information
- 4.6.2 Mallinckrodt Business Overview
- 4.6.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mallinckrodt Metformin Drugs Product Portfolio
- 4.6.5 Mallinckrodt Recent Developments
- 4.7 Teva Pharmaceuticals
- 4.7.1 Teva Pharmaceuticals Company Information
- 4.7.2 Teva Pharmaceuticals Business Overview
- 4.7.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva Pharmaceuticals Metformin Drugs Product Portfolio
- 4.7.5 Teva Pharmaceuticals Recent Developments
- 4.8 Torrent Pharmaceuticals
- 4.8.1 Torrent Pharmaceuticals Company Information
- 4.8.2 Torrent Pharmaceuticals Business Overview
- 4.8.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Torrent Pharmaceuticals Metformin Drugs Product Portfolio
- 4.8.5 Torrent Pharmaceuticals Recent Developments
- 4.9 Viatris
- 4.9.1 Viatris Company Information
- 4.9.2 Viatris Business Overview
- 4.9.3 Viatris Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Viatris Metformin Drugs Product Portfolio
- 4.9.5 Viatris Recent Developments
- 4.10 Novartis
- 4.10.1 Novartis Company Information
- 4.10.2 Novartis Business Overview
- 4.10.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Novartis Metformin Drugs Product Portfolio
- 4.10.5 Novartis Recent Developments
- 4.11 Sun Pharmaceutical Industries
- 4.11.1 Sun Pharmaceutical Industries Company Information
- 4.11.2 Sun Pharmaceutical Industries Business Overview
- 4.11.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sun Pharmaceutical Industries Metformin Drugs Product Portfolio
- 4.11.5 Sun Pharmaceutical Industries Recent Developments
5 Global Metformin Drugs Market Scenario by Region
- 5.1 Global Metformin Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metformin Drugs Sales by Region: 2021-2032
- 5.2.1 Global Metformin Drugs Sales by Region: 2021-2026
- 5.2.2 Global Metformin Drugs Sales by Region: 2027-2032
- 5.3 Global Metformin Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Metformin Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Metformin Drugs Revenue by Region: 2027-2032
- 5.4 North America Metformin Drugs Market Facts & Figures by Country
- 5.4.1 North America Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metformin Drugs Sales by Country (2021-2032)
- 5.4.3 North America Metformin Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Metformin Drugs Market Facts & Figures by Country
- 5.5.1 Europe Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metformin Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Metformin Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Metformin Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metformin Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metformin Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metformin Drugs Market Facts & Figures by Country
- 5.7.1 South America Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metformin Drugs Sales by Country (2021-2032)
- 5.7.3 South America Metformin Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Metformin Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metformin Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metformin Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metformin Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Metformin Drugs Sales by Type (2021-2032)
- 6.1.1 Global Metformin Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Metformin Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Metformin Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Metformin Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metformin Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Metformin Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metformin Drugs Sales by Application (2021-2032)
- 7.1.1 Global Metformin Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Metformin Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Metformin Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Metformin Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metformin Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Metformin Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metformin Drugs Value Chain Analysis
- 8.1.1 Metformin Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metformin Drugs Production Mode & Process
- 8.2 Metformin Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metformin Drugs Distributors
- 8.2.3 Metformin Drugs Customers
9 Global Metformin Drugs Analyzing Market Dynamics
- 9.1 Metformin Drugs Industry Trends
- 9.2 Metformin Drugs Industry Drivers
- 9.3 Metformin Drugs Industry Opportunities and Challenges
- 9.4 Metformin Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst